Second Sight Medical Products announced that it plans to offer shares of its common stock in a public offering worth $50 million. Los Angeles-based Second Sight priced the underwritten public offering of 10 million shares of common stock at a public offering price of $5 per share to yield gross proceeds of $50 million, according […]
Funding Roundup
Pear Therapeutics to go public via SPAC merger
Prescription digital therapeutics pioneer Pear Therapeutics announced today that it will go public by merging with a SPAC called Thimble Point Acquisition Corp. Boston-based Pear Therapeutics’ combination with the special purpose acquisition company (SPAC), whose management team is associated with the Pritzker Vlock Family Office, will result in a combined company named Pear Holdings Corp. […]
Cleerly launches digital heart attack prevention software following $43M Series B
Cleerly today said it has launched its digital care software for heart attack prevention following a $43 million Series B funding round. New York–based Cleerly’s digital care technology is a non-invasive coronary computed tomography angiography that performs coronary artery phenotyping through artificial intelligence. According to the company, it uses millions of annotated lab images to […]
MedTech 100 roundup: Industry climbs again
The medtech industry built off a strong performance two weeks ago with another uptick in the midst of an up-and-down year. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 18) at 110.64 points, producing a 0.9% rise from the 109.63-point mark set one week […]
Ortho surgical software firm Enhatch raises $9M
AI-enabled surgical software company Enhatch announced today that it raised $9 million in a recent funding round. Led by software growth equity firms Trousdale Capital and Apis Holdings, the latest round brings Enhatch’s total fundraising to $15 million. It has also enabled the Hoboken, N.J.–based company to double its staff to 40. One-third of employees […]
JMI Equity invests $120M in Greenlight Guru
Greenlight Guru announced that it has received a roughly $120 million investment from JMI Equity to support further development and sales growth for its medical device quality management software. The news comes half a year after Indianapolis-based Greenlight Guru launched its AI-powered Halo for Change Management, which provides recommendations of items impacted by a change […]
Fractyl raises $100M for diabetes reversal tech, renamed as Fractyl Health
Fractyl Labs today announced the closing of a $100 million Series F financing round in addition to a name change to Fractyl Health. Lexington, Mass.–based Fractyl Health received contributions to the round from new investors Maverick Capital, M28 Capital and Population Health Partners, while other new and existing investors participated, too. Get the full story at […]
Former FDA commissioner Hahn to join VC behind Moderna
Flagship Pioneering announced that former FDA commissioner Dr. Stephen Hahn will lead its Preemptive Medicine & Health Security initiative. A “bioinnovation platform company,” Flagship Pioneering has originated and fostered more than 100 scientific ventures totaling more than $90 billion in aggregate value, according to the company. Get the full story at our sister site, Drug […]
MedTech 100 roundup: Significant uptick for industry
The up-and-down nature of the medtech industry continues to carry through 2021, with a recent dip now followed by a rapid ascent. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 11) at 109.63 points, producing a 2.5% rise from the 106.96-point mark set one […]
Private equity firms making majority investment in Medline
Medline Industries will stay a privately-held, family-run medtech giant after a majority investment from private equity firms. Blackstone, Carlyle and Hellman & Friedman are making the investment in Medline, which media reports peg at $34 billion. Get the full story on our sister site Medical Design & Outsourcing.
CVRx is going the IPO route
CVRx plans to hold an IPO to raise up to $75 million as it seeks to further commercialize its neuromodulation device to treat the heart. That’s according to a June 4 registration statement with the U.S. Securities and Exchange Commission that follows up on a registration confidentially filed with the SEC in April. The plan […]
